Navigation Links
July Issue of Journal of Antimicrobial Chemotherapy Highlights,Study of Factive Tablets for Five-Day Treatment of,Community-Acquired Pneumonia

s have been reported infrequently. As with other fluoroquinolones, FACTIVE should be used with caution in patients with known or suspected CNS diseases. If CNS reactions occur, FACTIVE should be discontinued and appropriate measures instituted.

No significant drug-drug interactions were seen with theophylline, digoxin, oral contraceptives, cimetidine, omeprazole, and warfarin, although patients receiving a fluoroquinolone concomitantly with warfarin should be monitored closely. Drug-drug interactions include probenicid, sucralfate, antacids containing aluminum or magnesium, iron, multivitamins containing metal cations, and didanosine. The safety and effectiveness of FACTIVE in children, adolescents (less than 18 years of age), pregnant women, and lactating women have not been established. For complete safety and efficacy information, please see the full prescribing information available at www.factive.com.

Forward-Looking Statement

This news release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements with regard to the importance of a short course of therapy for the treatment of CAP. Forward-looking statements represent our management's judgment regarding future events. Forward-looking statements typically are identified by use of terms such as "may," "will," "should," "plan," "expect," "intend," "anticipate," "estimate," and similar words, although some forward-looking statements are expressed differently. We do not plan to update these forward-looking statements. You should be aware that our actual results could differ materially from those contained in the forward-looking statements due to a number of risks affecting our business. These risks include, but are not limited to (a) our ability to successfully commercialize and market ANTARA or FACTIVE due to: the limitations on our resources and experience in the commercialization of products
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
2. FDA Issues Safety Alert on Avandia
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
5. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
6. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
7. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics

Post Your Comments:
(Date:11/29/2009)...9 Researchers using functional mag...vation have found that men and women respond diffe... to a study presented today at the annual meeting ...). ,, "Men may direct more attention to sensory...them in terms of implications for required action,...
(Date:11/28/2009)... 28 Siemens Healthcare redefines ...4; (Total imaging matrix) technology and with its...oth technologies are introduced in the new MAGNETO... Skyra* 3T scanners at the 95th Scientific Assembl...f North America (RSNA) from November 29 to Decembe...
(Date:11/27/2009)...ption to prevent illnesses caused by subtypes A an...v. 27 The U.S. Food and...ople ages 18 years and older to prevent disease ca...(Logo: http://www.newscom.com/cgi-bin/prnh/200908...is Vaccines and Diagnostics in Siena, Italy, was a...
Breaking Medicine Technology:New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7FDA Approves Agriflu Seasonal Influenza Vaccine 2HCC Medical Insurance Services LLC Partners with Travel Insured 60407 1HCC Medical Insurance Services LLC Partners with Travel Insured 60407 2HCC Medical Insurance Services LLC Partners with Travel Insured 60407 3HCC Medical Insurance Services LLC Partners with Travel Insured 60407 4Undocumented Hispanics Face Health Care Roadblocks in U S 60405 1Undocumented Hispanics Face Health Care Roadblocks in U S 60405 2Scientist Throws Curve Into Breaking Ball Debate 60403 1Scientist Throws Curve Into Breaking Ball Debate 60403 2Scientist Throws Curve Into Breaking Ball Debate 60403 3
...ITY, June 14, 2007 /PRNewswire/ -- Prolexys,Pharma...bing the,properties of the selective small molecul... applied the company,s,chemi-proteomics technology... The results, to be published in the June 14, 2007...inds to mitochondrial,voltage- dependent anion cha...
...nn.--(BUSINESS WIRE)--Jun 13, 2007 - Neurogen,Corp...rom previous,Phase 1 and Phase 2a clinical studies...reatment of insomnia, were presented in two,sessio...ted,Professional Sleep Societies (APSS) in Minneap...h NG2-73 in chronic insomnia patients,are currentl...
Other Medicine Technology:Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5
(Date:11/29/2009)...quot;The YogaForce A-Line Athletic Mat is great. ...l, M.D., author and physician best known for estab...medicine. Go to www.yogaforce.com and order the...list. , San Francisco, CA... holidays, the YogaForce newly patented, revolutio...
(Date:11/29/2009)...raditional healthcare,s uncertain future and risin...ative care. Affordable Acupuncture Scottsdale answ...ovember 29, 2009 -- Affordable Acupuncture, LLC op... has been met with enthusiasm and gratitude. Its i...ibuted to two things, need and cost. "As far...
(Date:11/28/2009)... 28 Welcome to syngo® ....inical routine from Siemens Healthcare. As the...em (PACS) from Siemens where 2D, 3D, and 4D read...is poised to change the way multimodality images a...n at the 95th Scientific Assembly and Annual Mee...
(Date:11/28/2009)... 28 Get ready for advanced visu...l routine when Siemens introduces syngo. ...l Meeting of the Radiological Society of North Ame...rmick Place (Booth #825, East Building/Lakeside Ce... Siemens, new imaging software for multimodality ...
(Date:11/28/2009)...likely to consider change after 30-minute psychoso...Y, Nov. 27 (HealthDay News) -- A program that gets...uld stop their dangerous behavior may lead to sign... found. , The new study included 184 men and wo...tions, who were randomly assigned to one of two in...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Drunk Drivers May Respond to Brief Motivational Interview 2
...e has proved to be efficient on animals according ...o.// "Perhaps we can cure HIV infection. This...ty of Western Ontario. Clinical trials of the va...ng said, "We have to be careful because we have do...
... Mayo clinic have conducted a randomised, placebo ...men to study the effects of the popular antiaging/...ort published in the New England Journal of Medici...es not have any marked impact on the popular measu...
...nder the effects of the country's worst epidemic o...45% of Indians having been infected by Chikungunya... In a statement issued yesterday by the WHO, o...in and high fever. So far the disease has spread t...
... vaccine developed by scientists in the US attacks...d help prevent the disease that has kills one mill...ed RTS, S and developed by Walter Reed Army Instit...here malaria is common, reported the science porta...
...ns Hopkins have shown that transplanting human ste...e Lou Gehrig’s disease delays the start of nerve//...rolongs life. The grafted stem cells develop into ...lerosis (ALS). The study is published in this week...
...chers have found that a protein that initiates a “...irects cell death for those cells damaged during//...l “bulls eye” for targeting anti-tumor drugs. The ...uality control inspector.” As normal cells divide,...
Other Medicine News:Health News:The Search For Eternal Youth-DHEA Not The Magic Potion 2Health News:45% of Indians Affected by Chikungunya Fever 2Health News:Human Stem Cells Delay Start of Lou Gehrig’s Disease in Rat 2Health News:Human Stem Cells Delay Start of Lou Gehrig’s Disease in Rat 3Health News:Protein as Potential Tactic to Prevent Tumors 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: